They also recorded a decline in CBF velocity during central apnea but only in 14% of central apneas, which contradicts the studies by Franklin et al. [68] and [72],
which reports a consistently low CBF velocity during central apnea. The reason for these contradictory results is unclear and the authors do not discuss their findings in comparison with others. The cerebral vascular reactivity to hypercapnia in patients with obstructive sleep apnea syndrome (OSAS) was investigated by Diomedi et al., 1998 [73] and Placidi et al., 1998 [74] to evaluate the influence of hemodynamic changes caused by OSAS. They studied cerebral vascular reactivity to hypercapnia calculated by means of the breath holding index. The investigation was performed in the early morning, soon after awakening and in the late afternoon. OSAS patients showed significantly lower breath holding index values with respect BGJ398 datasheet to controls
SCH772984 solubility dmso both in the morning (0.57 vs. 1.40; p < 0.0001) and in the afternoon (1.0 vs. 1.51; p < 0.0001). In patients, breath holding index values in the afternoon were significantly higher than in the morning. The authors concluded that the data demonstrate a diminished vasodilator reserve in obstructive OSAS patients, particularly evident in the morning. This reduction of the possibility of cerebral vessels to adapt functionally in response to stimulation could be linked to hyposensitivity of cerebrovascular chemoreceptors after the continuous stress caused by nocturnal hypercapnia. Droste et al. [75] studied the potential effect of continuous positive airway pressure (CPAP) on cerebral perfusion. They investigated 23 patients with OSAS and 16 healthy young adults in the waking state. As compared with normal breathing CBF velocity of
MCA and pCO2 remained unchanged during CPAP. Systolic and diastolic blood pressure increased slightly by 1.2 mmHg and 1.1 mmHg, respectively. Cerebrovascular reactivity did not differ in the two groups. From their findings the authors concluded tuclazepam that nasal CPAP of 9 cmH2O is a safe treatment with respect to the maintenance of CBF. The study gives further evidence for the autoregulation’s capacity to maintain CBF velocity constant during different levels of intrathoracic pressure and different cerebral perfusion pressures. Another group of scientists [76] analyzed whether increasing levels of CPAP may affect cerebral hemodynamics, assessed by TCD in normal humans. They found that even low levels of CPAP delivered through a mouthpiece in awake, young volunteers led to a decrease in CBF velocity, measured by TCD. This fall in CBF velocity was associated with hypocapnia and with an increase in both cerebrovascular resistance and anxiety due to breathing against positive pressure. In a recent study Furtner et al. [63] investigated CBF velocity changes and vascular compliance in patients with OSAS using TCD and cerebral pulse transit time.